ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The aim of this document is to provide evidence‐based recommendations for the medical treatment of depression in adults with epilepsy. The working group consisted of members of an ad hoc Task Force of the International League Against Epilepsy (ILAE) Commission on Psychiatry, ILAE Executive and the International Bureau for Epilepsy (IBE) representatives. The development of these recommendations is based on a systematic review of studies on the treatment of depression in adults with epilepsy, and a formal adaptation process of existing guidelines and recommendations of treatment of depression outside epilepsy using the ADAPTE process. The systematic review identified 11 studies on drug treatments (788 participants, class of evidence III and IV); 13 studies on psychological treatments (998 participants, class of evidence II, III and IV); and 2 studies comparing sertraline with cognitive behavioral therapy (CBT; 155 participants, class of evidence I and IV). The ADAPTE process identified the World Federation of Societies of Biological Psychiatry guidelines for the biological treatment of unipolar depression as the starting point for the adaptation process. This document focuses on first‐line drug treatment, inadequate response to first‐line antidepressant treatment, and duration of such treatment and augmentation strategies within the broader context of electroconvulsive therapy, psychological, and other treatments. For mild depressive episodes, psychological interventions are first‐line treatments, and where medication is used, selective serotonin reuptake inhibitors (SSRIs) are first‐choice medications (Level B). SSRIs remain the first‐choice medications (Level B) for moderate to severe depressive episodes; however, in patients who are partially or non‐responding to first‐line treatment, switching to venlafaxine appears legitimate (Level C). Antidepressant treatment should be maintained for at least 6 months following remission from a first depressive episode but it should be prolonged to 9 months in patients with a history of previous episodes and should continue even longer in severe depression or in cases of residual symptomatology until such symptoms have subsided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., et al. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16cs10905 · Cited by 693
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Kerr, M. P., Mensah, S., Besag, F., de Toffol, B., Ettinger, A., Kanemoto, K., Kanner, A., Kemp, S., Krishnamoorthy, E., LaFrance Jr, W. C., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03276.x · Cited by 425
Self-citationDepression in epilepsy: A systematic review and meta-analysis
Fiest, K. M., Dykeman, J., Patten, S. B., Wiebe, S., Kaplan, G. G., Maxwell, C. J., Bulloch, A. G. M., & Jette, N. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b1ae0 · Cited by 424
Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders
Barry, J. J., Ettinger, A. B., Friel, P., Gilliam, F. G., Harden, C. L., Hermann, B., Kanner, A. M., Caplan, R., Plioplys, S., Salpekar, J., et al. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.04.005 · Cited by 249
Self-citationDunner, D. L., Zisook, S., Billow, A. A., Batey, S. R., Johnston, J. A., & Ascher, J. A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0705 · Cited by 180
Michaelis, R., Tang, V., Goldstein, L. H., Reuber, M., LaFrance, W. C., Lundgren, T., Modi, A. C., & Wagner, J. L. (2018) · Epilepsia · doi:10.1111/epi.14444 · Cited by 167
PEARLS depression treatment for individuals with epilepsy: A randomized controlled trial
Ciechanowski, P., Chaytor, N., Miller, J., Fraser, R., Russo, J., Unutzer, J., & Gilliam, F. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.06.003 · Cited by 130
PACES in epilepsy: Results of a self‐management randomized controlled trial
Fraser, R. T., Johnson, E. K., Lashley, S., Barber, J., Chaytor, N., Miller, J. W., Ciechanowski, P., Temkin, N., & Caylor, L. (2015) · Epilepsia · doi:10.1111/epi.13052 · Cited by 103
Chaytor, N., Ciechanowski, P., Miller, J. W., Fraser, R., Russo, J., Unutzer, J., & Gilliam, F. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.01.017 · Cited by 76
McLaughlin, D. P., & McFarland, K. (2011) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9299-z · Cited by 75
Cognitive Behaviour Therapy to Improve Mood in People with Epilepsy: A Randomised Controlled Trial
Gandy, M., Sharpe, L., Nicholson Perry, K., Thayer, Z., Miller, L., Boserio, J., & Mohamed, A. (2014) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2014.892530 · Cited by 52
Orjuela-Rojas, J. M., Martínez-Juárez, I. E., Ruiz-Chow, A., & Crail-Melendez, D. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.07.033 · Cited by 37
Cited by
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Gandy, M., Woldhuis, T., Wu, W., Youssef, M., Bisby, M. A., Dear, B. F., Heriseanu, A. I., & Scott, A. J. (2024) · Psychological Medicine · doi:10.1017/s0033291724001995 · Cited by 20
Third-wave psychotherapies to promote mental health in epilepsy: An updated systematic review
Makris, T., & Dorstyn, D. S. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108766 · Cited by 8
Metadata
- Authors
- Mula, M., Brodie, M. J., de Toffol, B., Guekht, A., Hecimovic, H., Kanemoto, K., Kanner, A. M., Teixeira, A. L., & Wilson, S. J.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2021-12-05
- Volume
- 63
- Issue
- 2
- Pages
- 316-334
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W4200382508
- Cited by
- 86
- References
- 16
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.